Panakeia
PrivateLast Round
Grant
Jul 1, 2024
Est. Valuation
$10.7M
Total Funding Raised
$9.49M
Company Overview
Panakeia is a biotechnology company that provides an AI-driven software platform for multi-omic biomarker profiling directly from tissue images to accelerate cancer diagnosis and inform precision treatment.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Drug Discovery, Precision Medicine, Medical Imaging, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Panakeia Comparables
Compare Panakeia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nucleai | 85% | |
| Imagene AI | 84% | |
| Aignostics | 81% |
Panakeia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 1, 2024 | ||||
| Grant | Apr 1, 2023 | ||||
| M&A | Sep 9, 2021 | ||||
| Seed | Oct 27, 2020 | ||||
| Grant | May 20, 2020 | ||||
Seed | Sep 26, 2019 |
Panakeia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Hoxton Ventures | Seed |
| Innovate UK | Grant |
| Phoenix Court Group | Seed |
| LocalGlobe | Seed |
| Entrepreneurs First | Seed, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Landmark metabolic and pathway activation data presented at AACR 2026.
- Apr 21, 2026
Presented new data at the AACR 2026 conference.
Panakeia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Panakeia's valuation, stock price, and market status.
Is Panakeia a public or private company?
Panakeia is a private company.
What is the current stock price of Panakeia?
Panakeia is a private company with no public stock price. No recent secondary market data is available.
How much is Panakeia worth (valuation)?
Panakeia's valuation is estimated at $10.7M based on funding round data.
Can I buy Panakeia stock?
Panakeia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Panakeia's last funding round?
Panakeia's most recent funding round was Grant on September 26, 2019.
Who are the main investors in Panakeia?
Key investors in Panakeia include Innovate UK, Entrepreneurs First.
Will Panakeia IPO soon?
No public IPO plans have been announced for Panakeia.
How can I track Panakeia secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Panakeia's secondary market activity and sign up for updates.